SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-221286
Filing Date
2022-08-15
Accepted
2022-08-15 17:06:41
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d361785ds3.htm S-3 414285
2 EX-1.2 d361785dex12.htm EX-1.2 209392
3 EX-4.5 d361785dex45.htm EX-4.5 277637
4 EX-4.6 d361785dex46.htm EX-4.6 274207
5 EX-5.1 d361785dex51.htm EX-5.1 13815
6 EX-5.2 d361785dex52.htm EX-5.2 6963
7 EX-23.1 d361785dex231.htm EX-23.1 1964
8 EX-FILING FEES d361785dexfilingfees.htm EX-FILING FEES 53795
9 GRAPHIC g361785g04p01.jpg GRAPHIC 61298
10 GRAPHIC g361785g37p38.jpg GRAPHIC 56256
11 GRAPHIC g361785g59p21.jpg GRAPHIC 58263
  Complete submission text file 0001193125-22-221286.txt   1474068
Mailing Address 93 WORCESTER STREET WELLESLEY MA 02481
Business Address 570 PRESTON ST. SUITE 400 LOUISVILLE KY 40202 502-398-9250
Talaris Therapeutics, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266875 | Film No.: 221166583
SIC: 2836 Biological Products, (No Diagnostic Substances)